Stable corneal regeneration four years after implantation of a cell-free recombinant human collagen scaffold
详细信息 查看全文
- 作者：Per Fagerholm ; Neil S. Lagali ; Jeb A. Ong ; Kimberley Merrett ; W. Bruce Jackson ; James W. Polarek ; Erik J. Suuronen ; Yuwen Liu ; Isabelle Brunette ; May Griffith
- 关键词：Cornea ; Collagen ; Transplantation ; Recombinant protein
- 刊名：Biomaterials
- 出版年：March, 2014
- 年：2014
- 卷：35
- 期：8
- 页码：2420-2427
- 全文大小：2410 K
文摘
We developed cell-free implants, comprising carbodiimide crosslinked recombinant human collagen (RHC), to enable corneal regeneration by endogenous cell recruitment, to address the worldwide shortage of donor corneas. Patients were grafted with RHC implants. Over four years, the regenerated neo-corneas were stably integrated without rejection, without the long immunosuppression regime needed by donor cornea patients. There was no recruitment of inflammatory dendritic cells into the implant area, whereas, even with immunosuppression, donor cornea recipients showed dendritic cell migration into the central cornea and a rejection episode was observed. Regeneration as evidenced by continued nerve and stromal cell repopulation occurred over the four years to approximate the micro-architecture of healthy corneas. Histopathology of a regenerated, clear cornea from a regrafted patient showed normal corneal architecture. Donor human cornea grafted eyes had abnormally tortuous nerves and stromal cell death was found. Implanted patients had a 4-year average corrected visual acuity of 20/54 and gained more than 5 Snellen lines of vision on an eye chart. The visual acuity can be improved with more robust materials for better shape retention. Nevertheless, these RHC implants can achieve stable regeneration and therefore, represent a potentially safe alternative to donor organ transplantation.